comparemela.com

Latest Breaking News On - Pharmaceuticals get rating - Page 1 : comparemela.com

Virginia Retirement Systems ET AL Sells 2,000 Shares of ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

Virginia Retirement Systems ET AL cut its stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Rating) by 5.3% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 35,600 shares of the biopharmaceutical company’s stock after selling 2,000 shares during the period. Virginia Retirement […]

China SXT Pharmaceuticals, Inc (NASDAQ:SXTC) Sees Large Growth in Short Interest

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC – Get Rating) saw a large growth in short interest in June. As of June 15th, there was short interest totalling 98,100 shares, a growth of 42.4% from the May 31st total of 68,900 shares. Currently, 5.6% of the company’s stock are sold short. Based on an average trading volume […]

CASI Pharmaceuticals (NASDAQ:CASI) Research Coverage Started at StockNews com

Stock analysts at StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Get Rating) in a report issued on Friday. The firm set a “hold” rating on the biotechnology company’s stock. A number of other equities research analysts have also recently commented on the stock. HC Wainwright reduced their target price on shares of […]

Zacks: Analysts Anticipate AVEO Pharmaceuticals, Inc (NASDAQ:AVEO) Will Announce Quarterly Sales of $25 60 Million

Brokerages expect AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO – Get Rating) to report $25.60 million in sales for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for AVEO Pharmaceuticals’ earnings. The lowest sales estimate is $24.95 million and the highest is $26.04 million. AVEO Pharmaceuticals reported sales of $7.56 million in the […]

Zacks: Brokerages Anticipate RVL Pharmaceuticals plc (NASDAQ:RVLP) Will Announce Quarterly Sales of $13 98 Million

Brokerages expect RVL Pharmaceuticals plc (NASDAQ:RVLP – Get Rating) to report $13.98 million in sales for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for RVL Pharmaceuticals’ earnings. The lowest sales estimate is $8.30 million and the highest is $24.54 million. RVL Pharmaceuticals reported sales of $11.51 million in the […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.